Sandoz: Ready to unleash its full potential on its own

Generics (77% of sales) and biosimilars (23%) are both versions of drugs whose patents have expired. However, they differ in nature and manufacturing complexity, since biosimilars are large, complex molecules, produced from living organisms and highly sensitive to manufacturing conditions. Thus, the…
© MarketScreener.com 2024